Skip to main content
. Author manuscript; available in PMC: 2022 Jun 9.
Published in final edited form as: Nano Lett. 2021 May 24;21(11):4692–4699. doi: 10.1021/acs.nanolett.1c00895

Figure 4.

Figure 4.

Therapeutic studies for 90Y-DOTA-UPSN. (A) Tumor growth curves. *Significantly smaller relative tumor volumes found for the group of mice injected with 90Y-DOTA-UPSN when compared to all other groups (p < 0.05, n = 5). (B) Overall survival curve demonstrating significant extension in median survival in the group treated with 90Y-DOTA-UPSN.